Genomic diversity of respiratory pathogens in clinical versus community surveillance: a comparative analysis of SARS-CoV-2, RSV, and influenza viruses in Washington State

Background Genomic surveillance of respiratory viruses typically relies on sequences from individuals seeking health care, and whether these sequences represent the viruses circulating in the community is not well-characterized. We aimed to compare the diversity, proportion, and dynamics of influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 between clinical and community samples. Methods In this retrospective comparative genomic analysis, we used whole-genome sequences from community-based surveillance studies in the Seattle area, and clinical sequences from the Washington State Department of Health. We compared clade proportions and dynamics, sequence-cluster diversity, non-synonymous mutations, and Ct values between clinical and community samples. Findings We analyzed 538 RSV sequences collected between 2019 and 2021 (278 community, 260 clinical), 1506 influenza sequences (260 community, 1246 clinical) between 2019 and 2020, and 8660 SARS-CoV-2 sequences (5923 community, 2737 clinical) from 2020 to 2022. Clade proportions did not differ between clinical and community samples for RSV or influenza, but differed for SARS-CoV-2: clades 21J (Delta) and 21K (Omicron BA.1) were more frequent in community samples and clade 22B (Omicron BA.5) in clinical samples. SARS-CoV-2 clinical sequence clusters were more diverse than community clusters, whereas RSV and influenza showed no significant difference. Several spike mutations associated with monoclonal antibody resistance were more prevalent in community samples for SARS-CoV-2. Ct values were lower in clinical samples for multiple SARS-CoV-2, RSV, and influenza clades. Interpretation Seasonal respiratory viruses had similar dynamics and diversity in clinical and community samples, whereas pandemic SARS-CoV-2 differed between settings. Genomic surveillance programs should combine clinical and community sampling, particularly during pandemics in order to better capture viral diversity.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.11.26367863
Primary Topic
Respiratory viral infections research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Genomic diversity of respiratory pathogens in clinical versus community surveillance: a comparative analysis of SARS-CoV-2, RSV, and influenza viruses in Washington State

Helen Y. Chu, Lauren A. Frisbie, Ana A. Weil, Christina M. Lockwood et al.
5 links
medRxiv
Respiratory viral infections research
preprint

Genomic diversity of respiratory pathogens in clinical versus community surveillance: a comparative analysis of SARS-CoV-2, RSV, and influenza viruses in Washington State

Helen Y. Chu, Lauren A. Frisbie, Ana A. Weil, Christina M. Lockwood, Pavitra Roychoudhury, Allison Black, Joshua M. Kirsch, Anna Elias-Warren
preprint en

Abstract

Background Genomic surveillance of respiratory viruses typically relies on sequences from individuals seeking health care, and whether these sequences represent the viruses circulating in the community is not well-characterized. We aimed to compare the diversity, proportion, and dynamics of influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 between clinical and community samples. Methods In this retrospective comparative genomic analysis, we used whole-genome sequences from community-based surveillance studies in the Seattle area, and clinical sequences from the Washington State Department of Health. We compared clade proportions and dynamics, sequence-cluster diversity, non-synonymous mutations, and Ct values between clinical and community samples. Findings We analyzed 538 RSV sequences collected between 2019 and 2021 (278 community, 260 clinical), 1506 influenza sequences (260 community, 1246 clinical) between 2019 and 2020, and 8660 SARS-CoV-2 sequences (5923 community, 2737 clinical) from 2020 to 2022. Clade proportions did not differ between clinical and community samples for RSV or influenza, but differed for SARS-CoV-2: clades 21J (Delta) and 21K (Omicron BA.1) were more frequent in community samples and clade 22B (Omicron BA.5) in clinical samples. SARS-CoV-2 clinical sequence clusters were more diverse than community clusters, whereas RSV and influenza showed no significant difference. Several spike mutations associated with monoclonal antibody resistance were more prevalent in community samples for SARS-CoV-2. Ct values were lower in clinical samples for multiple SARS-CoV-2, RSV, and influenza clades. Interpretation Seasonal respiratory viruses had similar dynamics and diversity in clinical and community samples, whereas pandemic SARS-CoV-2 differed between settings. Genomic surveillance programs should combine clinical and community sampling, particularly during pandemics in order to better capture viral diversity.

medRxiv
Washington State Department of Health (US), University of Washington (US), Fred Hutch Cancer Center (US)
Good health and well-being
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon